From a single facility to a global presence in 42+ countries, MEVAC's growth reflects our unwavering dedication to innovation and impact.
Since 2022, MEVAC partners with Kemin
Industries, a global leader in biotechnology
This partnership fuels our:
R&D Advancements: With Kemin’s scientific
expertise and resources.
Global Reach: Leveraging Kemin’s distribution
networks to expand into new markets.
Sustainability: Shared commitment to eco
friendly production and animal welfare
Driven by science and innovation, we aim to develop high-quality vaccines and services that address emerging health needs by combining agile research, uncompromising quality, and a science-led approach.
To craft science-driven vaccines that sustain the heartbeat of animal and human health, empowering a safer, healthier world.
Science First
Science First: Decisions rooted in research and data
Science First
Science First: Decisions rooted in research and data
Science First
Science First: Decisions rooted in research and data
Science First
Science First: Decisions rooted in research and data
Leadership with a shared passion for science and global impact.